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Abstract
Background: Hepatitis C virus (HCV) Core protein regulates multiple signaling pathways and alters cellular genes
expression responsible for HCV induced pathogenesis leading to hepatocellular carcinoma (HCC). Prevalence of
HCV genotype 3a associated HCC is higher in Pakistan as compare to the rest of world; however the molecular
mechanism behind this is still unclear. This study has been designed to evaluate the effect of HCV core 3a on
apoptosis and cell proliferation which are involved in HCC
Methodology: We examined the in vitro effect of HCV Core protein of genotype 3a and 1a on cellular genes
involved in apoptosis by Real time PCR in liver cell line (Huh-7). We analyzed the effect of HCV core of genotype
1a and 3a on cell proliferation by MTT assay and on phosphrylation of Akt by western blotting in Huh-7 cells.
Results: The HCV 3a Core down regulates the gene expression of Caspases (3, 8, 9 and 10), Cyto C and p53 which
are involved in apoptosis. Moreover, HCV 3a Core gene showed stronger effect in regulating protein level of p-Akt
as compared to HCV 1a Core accompanied by enhanced cell proliferation in Huh-7 cell line.
Conclusion: From the current study it has been concluded that reduced expression of cellular genes involved in
apoptosis, increased p-Akt (cell survival gene) and enhanced cell proliferation in response to HCV 3a core confirms
anti apoptotic effect of HCV 3a Core gene in Huh-7 that may lead to HCC.
Introduction
Hepatitis C virus (HCV) causes acute and chronic hepa-
titis which can lead to Hepatocellular carcinoma (HCC)
in a significant number of patients via induction of oxi-
dative stress, steatosis, insulin resistance, fibrosis and
liver cirrhosis [1,2]. HCV is a major health problem
with almost 350 million chronically infected individuals
worldwide [3], and 10% of the Pakistani population
being chronically infected with this viral pathogen with
a higher prevalence rate of HCV association HCC as
compared to the rest of the world [4,5]. HCV has a
positive single-stranded RNA genome of approximately
9.5 kb that encodes a large precursor polyprotein of
approximately 3000 amino acids. Among the processed
HCV proteins, the Core protein of 191 amino acids is
essential for nucleo-capsid formation in the viral particle
[6]. HCV Core protein exerts many biological functions
in the host cell, such as cellular growth, malignant
transformation and apoptosis, which may be involved in
HCV-related liver diseases by modulation of gene tran-
scription, cell proliferation, and cell death leading to
oxidative stress, liver steatosis and eventually HCC [7-9].
More interestingly, constitutive expression of HCV Core
protein induced HCC in transgenic mice; the expression
level of HCV Core protein in the liver of these mice was
similar to that in patients with chronic hepatitis C [10].
Apoptosis is central for the control and elimination of
viral infections. There are increasing evidences suggest-
ing that liver cell damage in chronic HCV infection is
mediated by apoptosis [11]. Enhanced apoptosis of
hepatocytes has been described during chronic HCV
infection and correlates with the degree of liver damage
[12,13]. HCV induced apoptosis is mediated by both
external and internal pathways. The impact of apoptosis
in chronic HCV infection is not well understood. It may
be harmful by triggering liver fibrosis, or essential in
interferon (IFN) induced HCV elimination. For virtually
all HCV proteins, pro- and anti-apoptotic effects have
* Correspondence: captainmalik@hotmail.com
1Centre of Excellence in Molecular Biology, University of the Punjab, Pakistan
Full list of author information is available at the end of the article
Jahan et al. Virology Journal 2011, 8:522
http://www.virologyj.com/content/8/1/522
© 2011 Jahan et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.been described, especially for the Core and E2 protein
[13]. HCV Core has pro- and anti-apoptotic effects in
death ligand e.g., TNF-a and CD95 ligand mediated
hepatocyte apoptosis has been described in a hepatoma
cell line [14,15]. In contrast, HCV Core protein inhibits
CD95 Ligand-mediated apoptosis by preventing Cyto-
chrome C (Cyto C) release from mitochondria and con-
secutive activation of Caspase-9, 3 and 7 [16]. Several
studies demonstrated binding of the HCV Core protein
to p53, either inhibiting or activating p53 following with
anti- or pro-apoptotic effects [17,18]. HCV counteracts
p53 growth suppression through activation of MAPK
and PI3K/Akt signaling cascades which enhances cell
growth and proliferation [19]. In some studies apoptosis
was inhibited in hepatoma through Core-dependent
phosphorylation and activation of STAT3 that induces
the anti-apoptotic bcl-XL [20].
Caspase-3, 8, 9 and 10, (proteases involved in apopto-
sis signaling cascade), Cyto C and p53 interaction is
important in apoptosis [11]. Very few studies have been
undertaken with respect to the HCV different genotypes
and further studies are needed in this connection so as
to fully expose the ambiguity of different response in
different genotypes. In mammals, regulation of caspase
in cell death is complex, however, Caspase-2, 8, 9 and
10 are initiator caspase, whereas Caspase-3, 6 and 7,
serve as effecter caspases and Caspase-8 as the key
initiator of death receptor-mediated apoptosis [21-23].
Cyto C is associated with Caspase-9 in intrinsic apopto-
sis pathway while p53 tumor suppressor gene is an
important marker in apoptosis [18,24]. Expression of
caspase family is higher in HCV infection, and enhanced
hepatocyte apoptosis occurs through the intrinsic apop-
tosis pathway via mitochondria [25,26]. Studies of cas-
pases were better alternative for investigating apoptosis
in HCV infection as caspase activation occurs earlier
than DNA cleavage [21,22].
Previously, we have shown the increased cell prolifera-
tion in HCV 3a Core transfected liver cells to under-
stand the molecular mechanisms underlying the
multifunction of HCV Core protein, and HCV 3a Core
protein activates Cox-2 and VEGF more as compared to
genotype 1a [27]. Akt acts as an important signal media-
tor, which regulates cell survival and proliferation
[28,29]. The mechanisms of cell proliferation and trans-
formation are intrinsically linked to the process of apop-
tosis. The Ras/phosphatidylinositol-3-kinase (PI3K)/Akt
pathway is critical in anti-apoptotic signaling [30]. In
this pathway, the serine-threonine kinase Akt directly
phosphorylates many substrates, including Bad, Caspase-
9, CREB, Forkhead and GSK-3, and is critical for cell
survival in response to growth factor stimulation.
In general, apoptosis is central to viral clearance. In
HCV-infected liver, however, despite enhanced
hepatocyte apoptosis, viral persistence is observed with
different frequencies in different genotypes, as due to
the lack of proofreading function of the RNA-dependent
RNA-polymerase (NS5B), HCV has a high mutation rate
and exists as genetically heterogeneous quasispecies in
individual patients [31-33]. To examine the role of HCV
Core protein on caspase signaling, we investigated the
expression levels of molecules downstream caspase sig-
naling including Caspases-3, 8, 9, and 10, Cyto C and
p53 which are most important in apoptotic pathway in
transfected Huh-7 cell line. Moreover, we examined the
activation of the PI(3)K/Akt pathway in cells expressing
HCV Core 1a and 3a protein.
Results
Effect of HCV Core gene on gene expression of Caspases,
Cyto C and p53
Monitoring of caspase activation might provide a reli-
able diagnostic tool to detect the degree of HCV-
mediated inflammatory liver damage and to evaluate the
effect of HCV genes on apoptotic pathways. The mRNA
expression of Caspase-3, 8, 9 and 10, Cyto C and p53
genes in Core (genotype 1a and 3a) transfected Huh-7
cells was observed. Results indicated a reduced level of
expression for these genes in genotype 3a Core (Core
3a) transfected cells as compared to the control and
genotype 1a Core transfected cells (Figure 1A). Further,
we analyzed sequences of HCV Core 1a and 3a protein
clones which we used in these experiment with consen-
sus reported sequence we found a significant nucleotide
difference in sequences of HCV core 1a and 3a. (Addi-
t i o n a lF i l e1 )T h e s eE x p r e s s i o no fH C Vc o r e1 aa n d3 a
were more profound in results obtained from Semi
quantitative method and Real-Time PCR at 48 hr as
compare to 72 and 96 hr (Additional File 2). Anti apop-
totic effect of HCV core 3a on cellular genes mainly
involved in apoptosis were more reflective in results
obtained from Real-Time PCR at 48 hr (Additional File
3). The effect of HCV Core gene of genotype 1a and 3a
on expression of cellular genes Caspase-3, 8, 9 and 10,
Cyto C and p53 were detected by Real-Time PCR using
gene specific-primers and SYBR Green mix (Fermentas).
A more reduced expression of Caspase-3, 8, 9 and 10,
Cyto C and p53 genes was observed in Core-transfected
cells for genotype 3a as compared to genotype 1a.
Reduction in the expression of Caspase-3, 8, 9 and 10,
Cyto C and p53 genes were observed i.e., 60%, 40%,
60%, 35%, 60%, 30% respectively as compare to mock
transfected cells (Figure 1B).
HCV 3a Core gene decreases expression of Caspase-3 at
protein
Caspase-3 is the most important down stream effecter
triggered by Caspase-8, a vital component of the
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Page 2 of 7extrinsic cell death pathway, so we determined the pro-
tein expression levels of Caspase-3 gene for both geno-
types (HCV 1a and 3a). Cell lysates from Huh-7 cells,
transfected with HCV 1a and 3a Core plasmid were
examined by western blot analysis using Core, Caspase-
3 and GAPDH specific antibodies. There was a signifi-
cant reduction in the expression levels of Caspase-3 pro-
tein in HCV 3a Core transfected Huh-7 cells as
compared to HCV 1a (Figure 2A). Furthermore, by
using densitometer analysis we confirmed that there was
55% reduction in protein level in Huh-7 cells transfected
with Core 3a as compare to mock (M) (Figure 2B).
HCV 3a Core protein activates the pAkt and increases cell
proliferation
It has been reported that activated Akt, a proximal
downstream effecter of the anti-apoptotic phosphatidyli-
nositol-3-kinase (PI3K) signaling pathway is critical in
anti-apoptotic signaling [19,34]. In order to observe
whether 1a and 3a differentially regulate the expression
of phosphorylated-Akt (p-Akt), Huh-7 cells were transi-
ently transfected with or without HCV genotype 1a and
3a Core expressing plasmids for 48 hrs. Significant
increase in the protein expression levels in HCV 3a gen-
otype was observed as compared to HCV 1a. Cellular
extracts from Huh 7 cells were consecutively immuno
detected using Core, Akt and p-Akt (Ser 473) specific
antibodies. (Figure 3A). The results showed that total
Akt protein levels were same for both genotypes while
only the p-Akt was increased. These results suggested
that HCV 3a Core protein activated Akt by phosphryla-
tion of Akt which shows that HCV 3a core has stronger
effect on activation of Akt as compared to HCV-1a
Core in Huh-7 which is cell survival gene and enhanced
cell growth. By densitometer we confirmed that there
was 45% increase in protein level of p-Akt in Huh-7
Figure 1 Effect of HCV Core on the gene Expression of
Caspase-3, 8, 9 and 10, Cyto C and p53 genes in Huh-7. A)
Huh-7 cells transiently transfected with HCV Core 1a (C1a), Core 3a
(C3a) vectors and pCR3.1 plasmid alone as mock (M) samples (0.4
μg DNA/well of each plasmid). Cells were harvested after 48 hr and
relative RNA determinations were carried out using semi-
quantitative RT-PCR. B) Comparison of gene expression Caspase-3, 8,
9, 10, Cyto C and p53 genes of in transiently transfected Huh-7
cells. All experiments were performed in 3 independent
experiments having triplicate samples in each. Error bars indicate,
mean S.D, *p < 0.01 verses mock.
Figure 2 HCV 3a Core gene decreases expression of Caspase-3
at protein level. A) Protein expression levels were determined by
western blot analysis from Huh-7 cell lysates after 48 hr transfection
with HCV Core 1a (C1a) and Core 3a (C3a) using specific antibody.
Protein levels for GAPDH gene are shown as internal control. B)
Blots were also normalized by measuring the amount of GAPDH
(histogram). Bars are mean of optical density ratio of each group.* p
< 0.001 verses control and Core 1a. GAPDH gene was used as
internal control for normalization in western blotting. All
experiments were performed in 3 independent experiments having
triplicate samples in each.
Jahan et al. Virology Journal 2011, 8:522
http://www.virologyj.com/content/8/1/522
Page 3 of 7cells transfected with Core 3a as compare to mock while
expression of total Akt was same (Figure 3B).
It has been reported that HCV Core enhances prolif-
eration with activation of p-Akt and increased levels of
proinflammatory molecule PGE2 which in turn promote
the growth of human HCC cells via VEGF [7]. So here
we determined as an indirect effect of HCV Core geno-
type 1a and 3a on activation of Akt and cell prolifera-
tion through MTT cell proliferation assay. Results
indicated significant enhanced cell proliferation with
HCV 3a genotype Core as compared with HCV 1a gen-
otype Core (Figure 3C).
Discussion
Kinetics and extent of hepatocytes apoptosis as well as
the pro- and anti-apoptotic mechanisms involved in
HCV infection remain unclear. Different HCV genotypes
and quasispecies may induce different effects, and stu-
dies on the contribution of genotypes or quasispecies to
the effects on apoptosis are largely missing. Overall, the
data regarding the role of different HCV proteins are
controversial and attribute to a given viral protein pro-
and anti-apoptotic effects, depending on the experimen-
tal system used. Several molecular interactions between
Core protein and cellular genes of the apoptotic
machinery have been found [13]. Different pro- and
anti-apoptotic effects of the HCV Core protein from an
individual patient have been described [33], suggesting
special properties of different quasispecies proteins.
Other studies showed Core-induced apoptosis through
mitochondrial Cyto C release and indirect activation of
bax TRAIL-induced apoptosis in hepatoma cells seems
enhanced by Core-dependent bid-cleavage [24]. Taken
together, it remains unclear whether HCV Core protein
inhibits or induces death receptor-mediated apoptosis of
hepatocytes. Our results are consistent to these all
e x p e r i m e n t si nw h i c hH C VC o r ei sf o u n dt oi n h i b i t
apoptosis, our results showed that HCV Core 3a inhibits
apoptosis by down regulating the expression of caspases
(Caspase-3, 7, 8, 9 and 10) Cyto C and p53 which are
involved in apoptotic pathways (Figure 1). Furthermore,
on comparative analysis of gene expression by real time
we observed significant reduction in HCV Core 3a
transfected cells. Our results showed that HCV 3a Core
down regulates the expression of these genes more than
Core of HCV genotype 1a. As Caspase-3 is the most
important down stream effecter triggered by Caspase-8,
a vital component of the extrinsic cell death pathway,
the down-regulation of Caspase-3 was further confirmed
by observing the reduction of Caspase-3 at protein level
by HCV 3a Core (Figure 2). Monitoring of Caspase acti-
vation might provide a reliable diagnostic tool to detect
the degree of HCV-mediated inflammatory liver damage
and to evaluate the efficacy of HCV therapy.
These finding are most important as our previous
study of oxidative stress leading to HCC pathway has
shown that HCV 3a Core has up-regulated the activa-
tion of Akt by its phosphorylation, also increasing PGE-
2 production and cell proliferation as compared to HCV
Core 1a [27]. We also confirmed that activation of Akt
was more in HCV Core 3a transfected liver cells as
compare to HCV Core 1a (Figure 3). Further we ana-
lyzed the effect of HCV Core 1a and 3a in Huh7 cells
and found HCV Core 3a increased cell proliferation as
compare to HCV Core 1a (Figure 3). Our results indi-
cated that HCV Core protein promoted activated the
anti-apoptotic signaling pathway including Akt and cas-
pase pathway thus linking anti-apoptotic signaling with
transcription machinery. This molecular mechanism of
anti-apoptotic model by HCV Core protein might play a
critical part of hepatocyte growth regulation and devel-
opment of human HCC mediated by chronic HCV
infection. Consistent with the “dual-signal” hypothesis
postulating coupling of the proliferation pathways with
those of cell death [35,36], these studies support our
hypothesis that HCV Core protein triggers two mechan-
isms: an anti-apoptotic PI(3)K/Akt pathway and
increases in cell proliferation. In fact, Bataller et al.
recently demonstrated that expression of HCV Core
Figure 3 H C V3 aC o r eg e n ei n c r e a s e sp - A k ta tp r o t e i nl e v e l
and increases cell proliferation. A) The protein expression levels
were determined by western blot analysis from Huh-7 cell lysates
transfected with HCV Core vectors of genotype 1a, 3a and effect on
p-Akt was analyzed using specific antibodies. GAPDH was used as
internal control for normalization in western blotting. B) Blots were
also normalized by measuring the amount of GAPDH (histogram).
Bars are mean of optical density ratio of each group.* p < 0.001
verses control and Core 1a. GAPDH gene was used as internal
control for normalization in western blotting. C) MTT assay showing
the proliferation of Huh-7 cells transfected with Mock. HCV-core 3a
and Core 1a, harvested at 48 hr and ob Otsuka M, served at 570 nm
wavelength. All experiments were performed in 3 independent
experiments having triplicate samples in each. Error bars indicate,
mean S.D, *p < 0.01 verses mock.
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tion in a Ras/ERK and PI(3)K/Akt-dependent manner.
Recently, it has been reported that PI(3)K/Akt pathway
was active in human liver tumors and in cultured hepa-
toma cells leading to proliferation of cells [37]. In agree-
ment with these results, a number of previous
investigations indicated that the inhibition of Akt in
many hepatoma cell lines leads to growth arrest.
Although the mechanisms explaining the activation of
Akt in hepatoma cells are still unclear, we demonstrated
that expression of HCV Core 3a protein resulted in
much higher Akt activity and increase cell proliferation
which may lead to HCC.
By taking together these all results it is confirmed that
HCV Core 3a is mainly involved in decreased apoptosis
and enhanced cells growth which can lead to HCC. As
it has been shown that HCV genotype 3a is mainly asso-
ciated with HCC in Pakistan [38] but mechanism was
not understood. Previously, we reported that HCV geno-
type 3a causes oxidative stress more than genotype 1a
and it is involved in HCV pathogenesis as HCV Core 3a
increased the expression of genes which are involved in
HCV pathogenesis indeed HCC [27]. HCV induced oxi-
dative stress and steatosis is involved in DNA damage
and HCC [39]. This study also confirms that HCV Core
3a is involved in HCV induced HCC by reduction of
apoptosis and induction of cell proliferation by activa-
tion of Akt which is mainly involved in cell survival and
cell growth. In conclusion, the present study for the first
time suggest an interaction of HCV Core 3a for regulat-
ing the genes involved in HCV pathogenesis which may
provide a better understanding for genome-specific
mechanisms involved in disease progression by regulat-
ing caspase pathways, Tumor suppressor gene p53 and
Phosphorylation of Akt which directly or indirectly
increases cell proliferation leading to HCC.
Methodology
Source of samples
T h el o c a lH C V1 aa n d3 ap a t i e n t ’s serum samples used
in this investigation were obtained from the CAMB
(Center for Applied Molecular Biology) diagnostic
laboratory, Lahore and Jinnah Hospital Lahore, Pakistan
after quantification and genotype determination. Serum
samples were stored at -80°C prior to RNA extraction
for cloning and viral inoculation experiments. Patient’s
written consent and approval for this study was
obtained from institutional ethics committee.
Cell culture and transfection
Huh-7 cell line was kindly provided by Dr. Zafar Nawaz
(University of Miami, USA) and maintained in Dulbec-
co’s modified eagle medium (DMEM) supplemented
with 100 μg/ml penicillin; streptomycin and 10% fetal
bovine serum referred as complete medium (Sigma
Aldrich, USA) at 37°C with 5% CO2. The medium was
r e n e w e de v e r y3d a ya n dp a s s a g e de v e r y4 - 5d a y s .
Briefly, cells were seeded in 24-well (1 × 10
5/well) or 6-
well (5 × 10
5/well) plates and cultured in complete med-
ium until they became 60-80% confluent. As We have
described earlier that cells in 24-well plates were transi-
ently transfected with 0.4 μg of HCV-1a and 3a con-
structed vectors [27,40], in serum free media using
Lipofectamine™ 2000 (Invitrogen Life technologies, CA)
according to the manufacturer’s protocol. After 6hrs of
incubation at 37°C in 5% CO2, complete medium was
added to the cells. Protein analysis was carried out in 6-
well plates. Cells were harvested at 48 hrs post-transfec-
tion for gene expression analysis.
Total RNA isolation and gene expression analysis
Total RNA from transfected and non-transfected cells
was isolated using TRIzol reagent (Invitrogen life tech-
nologies, CA), 48 hrs post-transfection, cDNA was
synthesized with 1 μg of total RNA using Superscript III
cDNA synthesis kit (Invitrogen life technologies, CA)
and semi-quantitative RT-PCR was done using specific
primers described in (Table 1) for celluar genes involved
in apoptosis and GAPDH as control. Quantitative Real
Time PCR was carried out using Real Time ABI 7500
system (Applied Biosystems Inc, USA) with SYBR Green
mix (Fermentas International Inc, Canada) (Table 1).
The relative gene expression analysis was carried out by
the SDS 3.1 software (Applied Biosystems Inc, USA).
Each individual experiment was performed in triplicate.
Western blotting
T od e t e r m i n et h ee f f e c to fH C VC o r eg e n eo np r o t e i n
expression levels of caspase in the transfected and non-
transfected cells, cells were lysed using ProteoJET
Table 1 Sequences of primers used in Real Time PCR
No Gene Primer
1 Cap 3-F ATGGAAGCGAATCAATGGAC
2 Cap3-R GCCATGTCATCATCAACACC
3 Cap 8-F TATGGCACTGATGGACAGGA
4 Cap8-R GCAGAAAGTCAGCCTCATCC
5 Cap9-F ATGTCGTCCAGGGTCTCAAC
6 Cap9-R GGAAACTGTGAACGGCTCAT
7 Cap10-F AGTGACAGGTATGGGCGTTC
8 Cap10-R GCAGCACCTCAACTGTACCA
9 Cyt-F ATTGGCGGCTGTGTAAGAGT
10 Cyt-R CTGTCTACGGCACAGATGGA
11 p53-F GGCCCACTTCACCGTACTAA
12 p53-R GTGGTTTCAAGGCCAGATGT
13 GAPDH-F ACCACAGTCCATGCCATCAC
14 GAPDH-R TCCACCACCCTGTTGCTGTA
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amounts of total proteins were subjected to electrophor-
esis on 12% SDS-PAGE and electrophoretically trans-
ferred to a nitrocellulose membrane according to the
manufacturer’s protocol (Bio-Rad, CA). After blocking
non-specific binding sites with 5% skimmed milk, blots
were incubated with primary monoclonal antibodies
specific to HCV Core, Caspase-3 and GAPDH genes
(Santa Cruz Biotechnology Inc, USA) and secondary
Horseradish peroxidase-conjugated anti-goat anti-mouse
antibody (Sigma Aldrich, USA). The protein expressions
were evaluated using chemiluminescence’s detection kit
(Sigma Aldrich, USA).
Cell Proliferation Assay
Approximately 2 × 103 Huh-7 cells were seeded into
96-well tissue culture plates for 48 hrs prior to transfec-
tion. Huh-7 cells were transiently transfected with 0.1
μg/well of HCV Core 1a and 3a plasmids and a negative
control in serum-free media using Lipofectamine™
2000 (Invitrogen) according to the manufacturer’s proto-
col. After 6 hrs incubation at 37°C in 5% CO2, CCM
(complete culture media) was added to the cells. The
MTT colorimetric assay was performed to detect cell
proliferation after 48 hrs of incubation. The absorbance
of resulting formazan crystals (solubilized with DMSO)
was read at 590 nm on ELISA plate reader.
Statistical analysis
All statistical analysis was done using SPSS software
(version 16.0, SPSS Inc). Data are presented as mean ±
SD. Numerical data were analyzed using student’st - t e s t
and ANOVA. P value < 0.05 was considered statistically
significant.
Additional material
Additional file 1: Sequence analysis of HCV Core 1a and 3a protein
clones.
Additional file 2: Time course of HCV Core gene of genotype 1a
and 3a A.
Additional file 3: Time course effect of HCV Core of genotype 1a
and 3a on cellular genes involved in apoptosis.
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